Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serendipity-PB1: PB in Polyuric Patients With NDI or ADPKD
NCT05190744Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Sep 2022
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Patent blue V in nephrogenic diabetes insipidus (NDI), autosomal dominant polycystic kidney disease (ADPKD), polyuria, sponsored by Mayo Clinic. Started Sep 2022; status: completed.
02
Drugs
Patent blue V
03
Conditions
nephrogenic diabetes insipidus (NDI)autosomal dominant polycystic kidney disease (ADPKD)polyuria
Beyond the preview
Go deeper on NCT05190744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05190744.